Dr. Stephanie Smith-Marrone, MD

Dr. Smith-Marrone practices at NewYork-Presbyterian Westchester in Bronxville, New York.

Dr. Smith-Marrone's NPI, 1912037193, was assigned on March 6, 2007. Dr. Smith-Marrone graduated from Renaissance School of Medicine at Stony Brook University in 2001. Dr. Smith-Marrone holds New York license 235387.

Dr. Smith-Marrone's primary practice is NewYork-Presbyterian Westchester, at 55 Palmer Ave, Bronxville, NY 10708. The practice phone is (914) 787-5008.

Dr. Smith-Marrone's primary practice is NewYork-Presbyterian Westchester in Bronxville, New York. Dr. Smith-Marrone is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is NewYork-Presbyterian Medical Group Westchester. Dmand AI also links Dr. Smith-Marrone to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Smith-Marrone practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Smith-Marrone's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Smith-Marrone is board certified in medical oncology by the American Board of Internal Medicine. Dr. Smith-Marrone is licensed in New York.

Dmand AI lists breast cancer, chronic leukemia, lung cancer, lymphoma and prostate cancer among the conditions Dr. Smith-Marrone treats.

CMS data shows 458 Medicare services from Dr. Smith-Marrone across 6 procedure codes in 2024, for 76 Medicare patients. Medicare paid $38,033 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 76 Medicare patients who saw Dr. Smith-Marrone in 2024. The largest group is 75 to 84, with 31 patients. 75% of them have cancer, and 75% have high blood pressure. 25% are also on Medicaid. Their average risk score is 2.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Smith-Marrone's median patient age at 77, with 45% women.

In 2024, Dr. Smith-Marrone wrote 493 Medicare Part D claims for 57 patients. 85% of them were for generic drugs. CMS names the drug for 354 of them, across 13 drugs with 11 or more claims each, at $299,131 in total drug cost. In 2023, CMS named 201 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Smith-Marrone for performance year 2024, reported through an alternative payment model (APM). Dr. Smith-Marrone accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Smith-Marrone as offering telehealth.

Dmand AI links 5 papers to Dr. Smith-Marrone, published from 2015 to 2016. 2015 was the busiest year, with 2. The most frequent topics are Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols and Carcinoma, Squamous Cell. Dr. Smith-Marrone's most frequent co-authors are Han Xiao, MD, Nancy Lee, MD and William Stuart Asch, MD, PhD.

CMS Open Payments shows 6 general payments to Dr. Smith-Marrone from 6 drug and device companies from 2016 to 2017. Food and beverage make up the largest share, 94% of the total. Sirtex Medical Inc paid the most, $137.

Dr. Smith-Marrone graduated from Renaissance School of Medicine at Stony Brook University in 2001. Dr. Smith-Marrone is a member of ASCO.

Dr. Smith-Marrone is in network with 8 carriers, including Aetna, Elevance and MVP Health Care. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.